1amd: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1amd" size="450" color="white" frame="true" align="right" spinBox="true" caption="1amd" /> '''NMR STUDY OF DNA (5'-D(*TP*GP*TP*AP*CP*A)-3'...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1amd.jpg|left|200px]]<br /><applet load="1amd" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1amd.jpg|left|200px]]<br /><applet load="1amd" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1amd" />
caption="1amd" />
'''NMR STUDY OF DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') SELF-COMPLEMENTARY DUPLEX COMPLEXED WITH A BIS-DAUNORUBICIN WP-652, MINIMIZED AVERAGE STRUCTURE'''<br />
'''NMR STUDY OF DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') SELF-COMPLEMENTARY DUPLEX COMPLEXED WITH A BIS-DAUNORUBICIN WP-652, MINIMIZED AVERAGE STRUCTURE'''<br />


==Overview==
==Overview==
In the search for new generations of anthracycline drugs, lower cytotoxic, side effects and higher activity against resistant cancer cells are two, major goals. A new class of bis-intercalating anthracycline drugs has been, designed, synthesized, and shown to have promising activity against, multidrug-resistant cells. Two daunorubicins symmetrically linked together, via a p-xylenyl group, either at their N3' (compound WP631) or N4' sites, (compound WP652), exhibit extraordinary DNA binding affinities. We have, used high-resolution NRM studies to understand the DNA binding mode of, these two new bis-daunorubicin anticancer compounds. The structures of the, WP631-d(ACGTACGT)2 and the WP652-d(TGTACA)2 complexes have been determined, by NOE-restrained refinement. WP631 binds strongly to the, 5'-CG(A/T)(A/T)CG hexanucleotide sequence, with the aglycons intercalated, between the two CpG sites at both ends of the hexanucleotide sequence. The, overall conformation of the WP631-d(CGTACG)2 part is remarkably similar to, the crystal structure of the 2:1 complex of daunorubicin and d(CGTACG)2, as predicted previously [Gao, Y.-G., &amp; Wang, A.H.H. (1996), J. Biomol., Struct. Dyn. 13, 103-117]. In contrast, the related bis-intercalator WP652, prefers the 5'-PyGTPu tetranucleotide sequence, with the aglycons, intercalated between the PypG and TpPu sites. The binding of WP652 to DNA, results in a severely distroted B-DNA duplex with the p-xylenyl tether, moiety significantly protruded away from the bottom of the minor groove., While WP652 in some ways behaves similarly to other anticancer, bis-intercalating antibiotics (e.g., triostine A and echinomycin), the, detailed interactions between those two classes of bis-intercalators are, quite different.
In the search for new generations of anthracycline drugs, lower cytotoxic side effects and higher activity against resistant cancer cells are two major goals. A new class of bis-intercalating anthracycline drugs has been designed, synthesized, and shown to have promising activity against multidrug-resistant cells. Two daunorubicins symmetrically linked together via a p-xylenyl group, either at their N3' (compound WP631) or N4' sites (compound WP652), exhibit extraordinary DNA binding affinities. We have used high-resolution NRM studies to understand the DNA binding mode of these two new bis-daunorubicin anticancer compounds. The structures of the WP631-d(ACGTACGT)2 and the WP652-d(TGTACA)2 complexes have been determined by NOE-restrained refinement. WP631 binds strongly to the 5'-CG(A/T)(A/T)CG hexanucleotide sequence, with the aglycons intercalated between the two CpG sites at both ends of the hexanucleotide sequence. The overall conformation of the WP631-d(CGTACG)2 part is remarkably similar to the crystal structure of the 2:1 complex of daunorubicin and d(CGTACG)2, as predicted previously [Gao, Y.-G., &amp; Wang, A.H.H. (1996), J. Biomol. Struct. Dyn. 13, 103-117]. In contrast, the related bis-intercalator WP652 prefers the 5'-PyGTPu tetranucleotide sequence, with the aglycons intercalated between the PypG and TpPu sites. The binding of WP652 to DNA results in a severely distroted B-DNA duplex with the p-xylenyl tether moiety significantly protruded away from the bottom of the minor groove. While WP652 in some ways behaves similarly to other anticancer bis-intercalating antibiotics (e.g., triostine A and echinomycin), the detailed interactions between those two classes of bis-intercalators are quite different.


==About this Structure==
==About this Structure==
1AMD is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with BNR as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1AMD OCA].  
1AMD is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=BNR:'>BNR</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AMD OCA].  


==Reference==
==Reference==
Line 13: Line 13:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Robinson, H.]]
[[Category: Robinson, H.]]
[[Category: Wang, A.H.J.]]
[[Category: Wang, A H.J.]]
[[Category: BNR]]
[[Category: BNR]]
[[Category: bis-intercalator]]
[[Category: bis-intercalator]]
Line 21: Line 21:
[[Category: dna]]
[[Category: dna]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sat Nov 24 23:04:20 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:46:00 2008''